DRUG BIOAVAILABILITY AND ITS CLINICAL SIGNIFICANCEWELLING PG.1980; PROGR. DRUG. METABOL.; GBR; DA. 1980; VOL. 4; PP. 131-163; BIBL. 5 P.Article

DOSE ADJUSTMENT IN RENAL FAILURE = AJUSTEMENT DES DOSES DANS L'INSUFFISANCE RENALEWELLING PG.1975; J. PHARM. SCI.; U.S.A.; DA. 1975; VOL. 64; NO 1; PP. 175-176; BIBL. 1REF.Article

INFLUENCE OF FOOD AND DIET ON GASTROINTESTINAL DRUG ABSORPTION. A REVIEW.WELLING PG.1977; J. PHARMACOKINET. BIOPHARMACEUT.; G.B.; DA. 1977; VOL. 5; NO 4; PP. 291-334; BIBL. 5 P.Article

HIGH-PRESSURE LIQUID CHROMATOGRAPHIC DETERMINATION OF PROMETHAZINE PLASMA LEVELS IN THE DOG AFTER ORAL, INTRAMUSCULAR, AND INTRAVENOUS DOSAGEPATEL RB; WELLING PG.1982; JOURNAL OF PHARMACEUTICAL SCIENCES; ISSN 0022-3549; USA; DA. 1982; VOL. 71; NO 5; PP. 529-532; BIBL. 15 REF.Article

PHARMACOKINETICS OF ACETYLMETHADOLS. I: GAS-LIQUID CHROMATOGRAPHIC DETERMINATION OF L-ALPHA -ACETYLMETHADOL AND ITS MAJOR METABOLITES IN PLASMATSE FLS; WELLING PG.1980; BIOPHARM. DRUG DISPOS.; GBR; DA. 1980; VOL. 1; NO 4; PP. 203-209; BIBL. 7 REF.Article

PHARMACOKINETICS OF INTRAVENOUS ERYTHROMYCINWELLING PG; CRAIG WA.1978; J. PHARM. SCI.; USA; DA. 1978; VOL. 67; NO 8; PP. 1057-1059; BIBL. 14 REF.Article

CALCULATION OF SERUM DIGOXIN LEVELS IN PATIENTS WITH NORMAL AND IMPAIRED RENAL FUNCTION.PAULSON MF; WELLING PG.1976; J. CLIN. PHARMACOL.; U.S.A.; DA. 1976; VOL. 16; NO 11-12; PP. 660-665; BIBL. 19 REF.Article

EFFECT OF DOSE SIZE ON THE PHARMACOKINETICS OF INTRAVENOUS HYDROCORTISONE DURING ENDOGENOUS HYDROCORTISONE SUPPRESSIONTOOTHAKER RD; WELLING PG.1982; J. PHARMACOKINET. BIOPHARM.; ISSN 0090-466X; USA; DA. 1982; VOL. 10; NO 2; PP. 147-156; BIBL. 22 REF.Article

INFLUENCE OF FOOD AND FLUID VOLUME ON CHLOROTHIAZIDE BIOAVAILABILITY: COMPARISON OF PLASMA AND URINARY EXCRETION METHODSWELLING PG; BARBHAIYA RH.1982; J. PHARM. SCI.; ISSN 0022-3549; USA; DA. 1982; VOL. 71; NO 1; PP. 32-35; BIBL. 17 REF.Article

THE INFLUENCE OF FOOD ON THE ABSORPTION OF ANTIMICROBIOL AGENTSWELLING PG; TSE FLS.1982; J. ANTIMICROB. CHEMOTHER.; ISSN 0305-7453; GBR; DA. 1982; VOL. 9; NO 1; PP. 7-27; BIBL. 4 P.Article

BIOAVAILABILITY OF PARENTERAL DRUGS. I: INTRAVENOUS AND INTRAMUSCULAR DOSESTSE FLS; WELLING PG.1980; J. PARENT. DRUG ASSOC.; ISSN 0161-1933; USA; DA. 1980; VOL. 34; NO 5; PP. 409-421; BIBL. 26 REF.Article

RELATIVE BIOAVAILABILITY OF PREDNISONE AND PREDNISOLONE IN MANTSE FLS; WELLING PG.1979; J. PHARM. PHARMACOL.; GBR; DA. 1979; VOL. 31; NO 7; PP. 492-493; BIBL. 14 REF.Article

PHARMACOKINETICS OF METHSUXIMIDE AND A MAJOR METABOLITE IN DOGS.DOBRINSKA MR; WELLING PG.1977; J. PHARM. SCI.; U.S.A.; DA. 1977; VOL. 66; NO 5; PP. 688-692; BIBL. 20 REF.Article

THE PHARMACOKINETICS OF METRONIDAZOLE AND TINIDAZOLE IN MAN = PHARMACOCINETIQUE DU METRONIDAZOLE ET DU TINIDAZOLE CHEZ L'HOMMEWELLING PG; MONRO AM.1972; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1972; VOL. 22; NO 12; PP. 2128-2132; ABS. ALLEM.; BIBL. DISSEM.Serial Issue

PHARMACOKINETICS OF ACETYLMETHADOLS. II: PLASMA LEVELS OF D- AND L-ALPHA -ACETYLMETHADOL AND THEIR MAJOR METABOLITES IN THE DOGTSE FLS; WELLING PG.1980; BIOPHARM. DRUG DISPOS.; ISSN 0142-2782; GBR; DA. 1980; VOL. 1; NO 5; PP. 221-233; BIBL. 24 REF.Article

PROTEIN BINDING OF ANTIMICROBIALS: CLINICAL PHARMACOKINETIC AND THERAPEUTIC IMPLICATIONS.CRAIG WA; WELLING PG.1977; CLIN. PHARMACOKINET.; NETHERL.; DA. 1977; VOL. 2; NO 4; PP. 252-268; BIBL. 4 P.Article

SIMULTANEOUS DETERMINATION OF ACETYLMETHADOL AND ITS MAJOR METABOLITES BY GAS-LIQUID CHROMATOGRAPHY.TSE FLS; WELLING PG.1977; J. CHROMATOGR.; NETHERL.; DA. 1977; VOL. 135; NO 1; PP. 205-207; BIBL. 1 REF.Article

BLOOD LEVELS FROM A SUSTAINED-RELEASE DOSAGE FORM. = LES TAUX SANGUINS A PARTIR D'UNE FORME GALENIQUE A LIBERATION PROLONGEEDOBRINSKA MR; WELLING PG.1975; J. PHARM. SCI.; U.S.A.; DA. 1975; VOL. 64; NO 10; PP. 1728-1729; BIBL. 5 REF.Article

EFFECT OF DOSE SIZE ON THE PHARMACOKINETICS OF ORAL HYDROCORTISONE SUSPENSIONTOOTHAKER RD; CRAIG WA; WELLING PG et al.1982; JOURNAL OF PHARMACEUTICAL SCIENCES; ISSN 0022-3549; USA; DA. 1982; VOL. 71; NO 10; PP. 1182-1185; BIBL. 15 REF.Article

AN IN VITRO MODEL FOR THE STUDY OF ANTIBACTERIAL DOSAGE REGIMEN DESIGNTOOTHAKER RD; WELLING PG; CRAIG WA et al.1982; JOURNAL OF PHARMACEUTICAL SCIENCES; ISSN 0022-3549; USA; DA. 1982; VOL. 71; NO 8; PP. 861-864; BIBL. 19 REF.Article

PLASMA PROPRANOLOL CONCENTRATIONS IN RATS WITH ADJUVANT-INDUCED ARTHRITISBISHOP H; SCHNEIDER RE; WELLING PG et al.1981; BIOPHARM. DRUG DISPOS.; ISSN 0142-2782; GBR; DA. 1981; VOL. 2; NO 3; PP. 291-297; BIBL. 20 REF.Article

NICOTINE BASE PERMEATION THROUGH SILICONE ELASTOMERS: COMPARISON OF DIMETHYLPOLYSILOXANE AND TRIFLUOROPROPYLMETHYLPOLYSILOXANE SYSTEMS = LE PASSAGE DE LA NICOTINE BASE A TRAVERS DES ELASTOMERES SILICONIQUES: COMPARAISON DES SYSTEMES DIMETHYL POLYSILOXANE ET TRIFLUOROPROPYL METHYLPOLYSILOXANEGAGINELLA TS; WELLING PG; BASS P et al.1974; J. PHARM. SCI.; U.S.A.; DA. 1974; VOL. 63; NO 12; PP. 1849-1853; BIBL. 31REF.Article

INFLUENCE OF URINARY PH ON THE PHARMACOKINETICS OF CINOXACIN IN HUMANS AND ON ANTIBACTERIAL ACTIVITY IN VITROBARBHAIYA RH; GERBER AU; CRAIG WA et al.1982; ANTIMICROB. AGENTS CHEMOTHER.; ISSN 0066-4804; USA; DA. 1982; VOL. 21; NO 3; PP. 472-480; BIBL. 16 REF.Article

HIGH-PRESSURE LIQUID CHROMATOGRAPHIC DETERMINATION OF CHLOROTHIAZIDE AND HYDROCHLOROTHIAZIDE IN PLASMA AND URINE: PRELIMINARY RESULTS OF CLINICAL STUDIESBARBHAIYA RH; PHILLIPS TA; WELLING PG et al.1981; J. PHARM. SCI.; ISSN 0022-3549; USA; DA. 1981; VOL. 70; NO 3; PP. 291-295; BIBL. 17 REF.Article

BIOAVAILABILITY OF ORAL AND INTRAMUSCULAR PHENOBARBITAL.VISWANATHAN CT; BOOKER HE; WELLING PG et al.1978; J. CLIN. PHARMACOL.; U.S.A.; DA. 1978; VOL. 18; NO 2-3; PP. 100-105; BIBL. 17 REF.Article